D. van Schaardenburg

1.2k citations

34 papers · 747 indexed · h-index 9

Rheumatology top 1%
Radiology, Nuclear Medicine and Imaging top 10%
Immunology
Hematology top 10%
Genetics top 10%

Co-authors: Ben A. C. Dijkmans M. Nielen B.A.C. Dijkmans Irene E. van der Horst‐Bruinsma Dörte Hamann L Aarden A. R. van der Horst T. Huizinga
Topics: Rheumatoid Arthritis Research and Therapies (17 papers)Systemic Lupus Erythematosus Research (11 papers)Monoclonal and Polyclonal Antibodies Research (10 papers)
Cited by: Rheumatology Hematology Radiology, Nuclear Medicine and Imaging
Journals: Annals of the Rheumatic Diseases Osteoarthritis and Cartilage Lara D. Veeken
Partner nations: Netherlands United States Canada

In The Last Decade

D. van Schaardenburg

32 papers receiving 729 citations

Peers

Countries citing papers authored by D. van Schaardenburg

Since Specialization

Citations

This map shows the geographic impact of D. van Schaardenburg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. van Schaardenburg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. van Schaardenburg more than expected).

Fields of papers citing papers by D. van Schaardenburg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. van Schaardenburg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. van Schaardenburg. The network helps show where D. van Schaardenburg may publish in the future.

Co-authorship network of co-authors of D. van Schaardenburg

This figure shows the co-authorship network connecting the top 25 collaborators of D. van Schaardenburg. A scholar is included among the top collaborators of D. van Schaardenburg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. van Schaardenburg. D. van Schaardenburg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	POS0456 POSSIBLE MECHANISTIC PATHWAYS OF THE EFFECTIVE “PLANTS FOR JOINTS” LIFESTYLE AND DIETARY INTERVENTION FOR RHEUMATOID ARTHRITIS 2024 ·Annals of the Rheumatic Diseases ·(unknown),M. S. Pereira,Sylvio Redanz,André Gessner,(unknown),Martin Kriegel,Mario M. Zaiss,D. van Schaardenburg	1
2	OP0217 LONG-TERM EFFECTIVENESS OF A LIFESTYLE INTERVENTION FOR OSTEOARTHRITIS: TWO-YEAR FOLLOW-UP AFTER THE “PLANTS FOR JOINTS” RANDOMIZED CLINICAL TRIAL 2024 ·Annals of the Rheumatic Diseases ·(unknown),(unknown),Marike van der Leeden,Marie‐Jeanne P. Gerritsen,Jos W. R. Twisk,M. van der Esch,Henriët van Middendorp,Peter J.M. Weijs,D. van Schaardenburg	0
3	POS0181 EFFECT OF A MULTIDISCIPLINARY LIFESTYLE PROGRAM ON PATIENTS WITH METABOLIC SYNDROME-ASSOCIATED OSTEOARTHRITIS: THE PLANTS FOR JOINTS RANDOMIZED CONTROLLED TRIAL 2022 ·Annals of the Rheumatic Diseases ·(unknown),(unknown),Marike van der Leeden,Martijn Gerritsen,M. van der Esch,D. van Schaardenburg	1
4	Patient perspective on remission in rheumatoid arthritis: Validation of patient reported outcome instruments to measure absence of disease activity 2021 ·Seminars in Arthritis and Rheumatism ·Linda A. Rasch,Maarten Boers,Willem F. Lems,D. van Schaardenburg,Susanna Proudman,Catherine Hill,Cátia Duarte,Bindee Kuriya,B. Davis,(unknown),Marieke Voshaar,L. van Tuyl	3
5	POS0379 DETERMINING IN WHICH PRECLINICAL STAGE HLA-SHARED EPITOPE ALLELES AND SMOKING EXERT THEIR EFFECT IN THE DEVELOPMENT OF RHEUMATOID ARTHRITIS 2021 ·Annals of the Rheumatic Diseases ·Fenne Wouters,(unknown),Laurette van Boheemen,Marloes Verstappen,X. Matthijssen,Ellis Niemantsverdriet,Rachel Knevel,D. van Schaardenburg,René E. M. Toes,(unknown)	2
6	Progression From Subclinical Inflammation to Overt Spondyloarthritis in First‐Degree Relatives of Patients in Association With HLA–B27: The Pre‐Spondyloarthritis Cohort 2021 ·Arthritis Care & Research ·(unknown),(unknown),Irene E. van der Horst‐Bruinsma,D. van Schaardenburg,F. van Gaalen,Astrid van Tubergen,A. Weel,Robert Landewé,Dominique Baeten,M. G. H. Van de Sande	6
7	THU0117 PERSONS AT RISK OF RHEUMATOID ARTHRITIS OR AXIAL SPONDYLOARTHRITIS HAVE DIFFERENT PERCEPTIONS ON PREVENTIVE INTERVENTION THAN RHEUMATOLOGISTS 2020 ·Annals of the Rheumatic Diseases ·Laurette van Boheemen,(unknown),Marieke M. ter Wee,(unknown),M. Van de Sande,D. van Schaardenburg	1
8	SAT0708 Symptoms indicative of inflammatory arthritis are common in the primary care population: findings from the symptoms in persons at risk of rheumatoid arthritis survey 2017 ·Annals of the Rheumatic Diseases ·Samantha Hider,Sara Müller,James A. Prior,Toby Helliwell,D. van Schaardenburg,(unknown),Karim Raza,(unknown)	2
9	THU0125 Prednisolone Causes Dose Related Unfavourable Effects on Body Composition in Early Rheumatoid Arthritis Patients During the First Year of Treatment 2015 ·Annals of the Rheumatic Diseases ·(unknown),L. van Tuyl,(unknown),(unknown),(unknown),Alexandre E. Voskuyl,D. van Schaardenburg,Willem F. Lems,Michael T. Nurmohamed	1
10	Symptom complexes in patients with seropositive arthralgia and in patients newly diagnosed with rheumatoid arthritis: a qualitative exploration of symptom development 2014 ·Lara D. Veeken ·Rebecca Stack,L. van Tuyl,Maurits Sloots,Lotte A van de Stadt,(unknown),(unknown),Christian Mallen,(unknown),Karim Raza,D. van Schaardenburg	69
11	SAT0037 Serum 14-3-3Eta Predicts the Risk of RA Development and Its Higher Titres Are Associated with Higher Risk 2014 ·Annals of the Rheumatic Diseases ·D. van Schaardenburg,Walter P. Maksymowych,Maarten Boers,Marian H. van Beers-Tas,A. Marotta	4
12	ANTI-CARBAMYLATED PROTEIN ANTIBODIES (ANTI-CARP) PRECEDE THE ONSET OF RHEUMATOID ARTHRITIS 2013 ·Annals of the Rheumatic Diseases ·Jinxia Shi,(unknown),Nivine Levarht,T. Huizinga,Dörte Hamann,D. van Schaardenburg,René E. M. Toes,Leendert A. Trouw	1
13	FRI0101 The value of gene signatures in the diagnosis of pre-clinical ra 2013 ·Annals of the Rheumatic Diseases ·Joyce Lübbers,(unknown),Saskia Vosslamber,J. Wesseling,D. van Schaardenburg,C. L. Verweij	1
14	Antibodies Against Porphyromonas Gingivalis Correlate with Rheumatoid Arthritis-Specific Auto-Immunity in Arthralgia Patients. 2012 ·University of Groningen research database (University of Groningen / Centre for Information Technology) ·Menke J. de Smit,Lotte A van de Stadt,Johanna Westra,Berber Doornbos‐van der Meer,Koen M. J. Janssen,Arjan Vissink,A.J. van Winkelhoff,Elisabeth Brouwer,D. van Schaardenburg	1
15	Venous and arterial thromboembolic events in adalimumab‐treated patients with antiadalimumab antibodies: A case series and cohort study 2011 ·Arthritis & Rheumatism ·(unknown),G. M. Bartelds,C. Krieckaert,Franktien Turkstra,Michael T. Nurmohamed,D. van Schaardenburg,Carla A. Wijbrandts,Paul P. Tak,Willem F. Lems,Ben A. C. Dijkmans,Richard M. van Vugt,Gertjan Wolbink	91
16	Discontinuation of infliximab and potential predictors of persistent low disease activity in patients with early rheumatoid arthritis and disease activity score-steered therapy: subanalysis of the BeSt study 2011 ·Annals of the Rheumatic Diseases ·Maries van den Broek,Naomi B. Klarenbeek,Linda Dirven,D. van Schaardenburg,(unknown),P. J. S. M. Kerstens,T. Huizinga,Ben A. C. Dijkmans,Cornelia F Allaart	98
17	Aggressive therapy in patients with early arthritis results in similar outcome compared with conventional care: the STREAM randomized trial 2011 ·Lara D. Veeken ·I C van Eijk,M. Nielen,Irene van der Horst‐Bruinsma,Gerhardus J. Tijhuis,(unknown),B.A.C. Dijkmans,D. van Schaardenburg	40
18	Treatment with TNF-α inhibitor infliximab might reduce hand osteoarthritis in patients with rheumatoid arthritis 2010 ·Osteoarthritis and Cartilage ·Melek Güler-Yüksel,Cornelia F Allaart,I. Watt,Y P M Goekoop-Ruiterman,Jeska K de Vries‐Bouwstra,D. van Schaardenburg,M V van Krugten,Ben A. C. Dijkmans,T. Huizinga,Willem F. Lems,M. Kloppenburg	63
19	Antibodies to citrullinated human fibrinogen (ACF) have diagnostic and prognostic value in early arthritis 2005 ·Annals of the Rheumatic Diseases ·M. Nielen,A. R. van der Horst,D. van Schaardenburg,Irene E. van der Horst‐Bruinsma,R J van de Stadt,L Aarden,B.A.C. Dijkmans,Dörte Hamann	147
20	THE RELATION BETWEEN CLASS-SPECIFIC SERUM RHEUMATOID FACTORS AND AGE IN THE GENERAL POPULATION 1993 ·Lara D. Veeken ·D. van Schaardenburg,(unknown),Henny G. Otten,F. C. Breedveld	65

About D. van Schaardenburg

D. van Schaardenburg is a scholar working on Rheumatology, Complementary and Manual Therapy and Radiology, Nuclear Medicine and Imaging, having authored 34 papers that have together received 747 indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (17 papers), Systemic Lupus Erythematosus Research (11 papers) and Monoclonal and Polyclonal Antibodies Research (10 papers). The work is most often cited by research in Rheumatology (628 citations), Hematology (149 citations) and Radiology, Nuclear Medicine and Imaging (209 citations). D. van Schaardenburg has collaborated with scholars based in Netherlands, United States and Canada. Frequent co-authors include Ben A. C. Dijkmans, M. Nielen, B.A.C. Dijkmans, Irene E. van der Horst‐Bruinsma, Dörte Hamann, L Aarden, A. R. van der Horst, T. Huizinga, R J van de Stadt and Paul P. Tak. Their work appears in journals such as Annals of the Rheumatic Diseases, Osteoarthritis and Cartilage and Lara D. Veeken.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact